期刊文献+

25-OH-D_2、25-OH-D_3与股骨颈骨密度的相关性研究 被引量:3

Correlation study between 25-OH-D_2,25-OH-D_3,and the bone mineral density of the femoral neck
下载PDF
导出
摘要 目的研究人体内25羟维生素D2(25-OH-D2)、25羟维生素D3(25-OH-D3)含量与股骨颈骨密度的相关性。方法利用双能X线骨密度测量法检测205例患者股骨颈骨密度,同时用高效液相色谱法检测其血清中25-OH-D2及25-OH-D3的含量,并根据维生素D(VitD)含量分析VitD与骨密度的关系。结果人体内VitD(25-OH-D2+25-OH-D3)含量与50岁以下者的股骨颈骨矿含量无相关性(P>0.05),与50岁以上者呈正向直线相关(P<0.05或P<0.01),男女性别均一致。结论对于50岁以上者,随着年龄的增长,其体内血清VitD的含量降低很可能会导致其股骨颈骨矿含量下降。 Objective To investigate the correlation between the content of the 25-hydroxyvitamin D2 ( 25-( OH ) D2 ) and 25-hydroxyvitamin (25-(OH)D3) and the bone mineral density of the femoral neck (femoral neck BMD).Methods The femoral neck BMD of 205 patients was detected using dual energy X-ray absorptiometry.The serum levels of 25-( OH) D2 and 25-( OH) D3 were determined using high performance liquid chromatography.The correlation between Vitamin D ( Vit D) content and the femoral neck BMD was analyzed.Results In patients younger than 50 years old, no correlation between the VitD (25-(OH)D2 and 25-(OH)D3) content and the femoral neck BMD was observed (P〉0.05).But in patients elder than 50 years old, a positive linear correlation was observed (P〈0.05 or P〈0.01).This existed both in men and women.Conclusion In patients elder than 50 years old, the serum Vit D level decreases along with the increase of age, which may cause a decline in the femoral neck BMD.
作者 宋红
机构地区 贵州省骨科医院
出处 《中国骨质疏松杂志》 CAS CSCD 北大核心 2014年第6期623-625,630,共4页 Chinese Journal of Osteoporosis
基金 贵州省人民医院-贵州省科学技术厅联合基金课题(黔科合LS字[2012]047号)
关键词 股骨颈骨密度 25-OH-D2 25-OH-D3 相关性 25-( OH) D2 25-( OH) D3 Femoral neck BMD Correlation
  • 相关文献

参考文献7

二级参考文献79

共引文献106

同被引文献50

  • 1邓浩华,徐焱成.男性2型糖尿病患者骨质疏松相关因素分析[J].公共卫生与预防医学,2006,17(3):75-76. 被引量:11
  • 2楼辰军,冯桂玲.维生素与人体健康[J].公共卫生与预防医学,2007,18(1):50-51. 被引量:7
  • 3Loreffilt B, Toss G, Granfirus AK. Bone mass in elderly pa- tients with Parkinson: s disease[J]. Acta Neurol Scand, 2007, 116(4) :248-254.
  • 4Evatt ML, Delong MR, Kumari M, et al. High prevalence of hypovitaminosis D status in patients with early Parkinson dis- ease[J]. Arch Neurol,2011,68(3) :314-319.
  • 5Fyfe I. Parkinson disease Reduced leve| o:[ dietary vitamin D is associated with PD[J]. Nat Rev Neurol, 2015,11 (2) : 68.
  • 6Peterson AL, Mancini M, Horak FB. The relationship between balance control and vitamin D in Parkinson' s disease-a pilot study[J]. Mov Disord,2013,28(8) : 1133-1137.
  • 7Meamar R, Maracy M, Chitsaz A, et al. Association betweenserum biochemical levels, related to bone metabolism and Par- kinson: s disease[J]. J Res Med Sci, 2013, 18 (Suppl. 1) $39-$42.
  • 8Sato Y, Honda Y, Nail M, et al. Amelioration of osteoporosis by menatetrenone in elderly female Parkinson: s disease patients with vitamin D deficiency[J]. Bone, 2002, 31 ( 1 ) : 114 118.
  • 9Lin WP, Wen CJ, Jiang CC, et al. Risk factors for hip fracture sites and mortality in older adults[J]. J Trauma,2011,71 (1): 191-197.
  • 10Ding H, Dhima K,Lockhart KC, et al. Unrecognized vitamin D3 deficiency is common in Parkinson disease: harvard biomar- ker study[J].Neurology,2013,81(17) : 1531 1537.

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部